Related Experiment Video
Updated: Jun 9, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Protein structural context of cancer mutations reveals molecular mechanisms and candidate driver genes
Diego Chillón-Pino1, Mihaly Badonyi1, Colin A Semple1
1MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Abstract:
Advances in protein structure determination and modeling allow us to study the structural context of human genetic variants on an unprecedented scale. Here, we analyze millions of cancer-associated missense mutations based on their structural locations and predicted perturbative effects. By considering the collective properties of mutations at the level of individual proteins, we identify distinct patterns associated with tumor suppressors and oncogenes. Tumor suppressors are enriched in structurally damaging mutations, consistent with loss-of-function mechanisms, while oncogene mutations tend to be structurally mild, reflecting selection for gain-of-function driver mutations and against loss-of-function mutations. Although oncogenes are difficult to distinguish from genes with no role in cancer using only structural damage, we find that the three-dimensional clustering of mutations is highly predictive. These observations allow us to identify candidate driver genes and speculate about their molecular roles, which we expect will have general utility in the analysis of cancer sequencing data.
Insights
This study analyzed millions of cancer mutations using protein structures. Tumor suppressor genes show damaging mutations, while oncogenes have milder, clustered mutations, aiding driver gene identification.
Area of Science:
- Genomics
- Structural Biology
- Cancer Research
Background:
- Protein structure determination and modeling enable large-scale analysis of human genetic variants.
- Understanding the structural context of mutations is crucial for cancer research.
Purpose of the Study:
- To analyze millions of cancer-associated missense mutations based on structural locations and predicted effects.
- To identify distinct patterns distinguishing tumor suppressors and oncogenes.
- To develop methods for identifying candidate cancer driver genes.
Main Methods:
- Analysis of millions of cancer-associated missense mutations.
- Assessment of mutation structural locations and predicted perturbative effects.
- Evaluation of collective protein mutation properties and three-dimensional clustering.
Main Results:
- Tumor suppressors are enriched in structurally damaging mutations (loss-of-function).
- Oncogene mutations are typically structurally mild, favoring gain-of-function.
- Three-dimensional mutation clustering is highly predictive for oncogenes, distinguishing them from non-cancer genes.
Conclusions:
- Distinct structural mutation patterns differentiate tumor suppressors and oncogenes.
- Structural analysis, particularly mutation clustering, aids in identifying cancer driver genes.
- Findings offer utility for analyzing cancer sequencing data and understanding molecular roles.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

